A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study To Evaluate Efficacy And Safety Of Dcvac/Pca Versus Placebo In Men With Metas
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
The main purpose of this study is to find out if the study drug given with standard of care chemotherapy makes people with prostate cancer live longer than giving the standard of care chemotherapy and a placebo. The investigators also hope to learn about how long it takes for the tumor to progress,
Criteria:
To Be Eligible For This Study, Patients Must Have Advanced Cancer Of The Prostate For Which The Doct
Keywords:
Sp005, Prostate, Castrate-Resistant , Cancer, Metastatic
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu